Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 900 of 1631 entries
View as:

Pharmacy Based Pharmacoepidemiological Observational Study With Aspirin Protect 100 mg

Phase: N/A Priority: Normal
NCT ID: NCT01669824 Org: User:
Start: 08/31/07 End: 05/31/09 Due: 05/31/10

Sorafenib Phase II Study for Japanese Anaplastic or Medullary Thyroid Carcinoma Patients

Phase: N/A Priority: Normal
NCT ID: NCT02114658 Org: User:
Start: 04/15/14 End: 08/02/16 Due: 08/02/17

Comparison Study of Vasovist® Magnetic Resonance Angiography (MRA) and an MRA With a Conventional Extracellular Contrast Agent With X-ray Angiography in Patients With Peripheral Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT00296855 Org: User:
Start: 02/28/06 End: 02/28/07 Due: 02/28/08

A Study to Determine the Correct Dose of Amikacin Which is Delivered Directly to the Lungs of Ventilated Patients as an Aerosol Via an Investigational Device Called the Pulmonary Delivery Device System (PDDS)

Phase: N/A Priority: Normal
NCT ID: NCT01004445 Org: User:
Start: 05/31/05 End: 06/30/06 Due: 06/30/07

Comparison of the Extent to Which the Drug Given as Two Different Capsule Sizes Becomes Available to the Body

Phase: N/A Priority: Normal
NCT ID: NCT04845841 Org: User:
Start: 04/09/21 End: 06/01/21 Due: 06/01/22

Study to Investigate the Effect of the A1 Agonist Capadenoson on Ventricular HR in Patients With Persistent or Permanent Atrial Fibrillation.

Phase: N/A Priority: Normal
NCT ID: NCT00568945 Org: User:
Start: 01/31/08 End: 12/31/08 Due: 12/31/09

SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study

Phase: N/A Priority: Normal
NCT ID: NCT00522951 Org: User:
Start: 08/31/07 End: 08/31/08 Due: 08/31/09

Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00901901 Org: User:
Start: 05/21/09 End: 05/23/18 Due: 05/23/19

An Observational Study Called FLAMINgO to Learn More About the Treatment Combination of Finerenone and SGLT2 Inhibitors in People With Long-term Kidney Disease (Chronic Kidney Disease) Together With Type 2 Diabetes by Using Routine Medical Care Data and Past Clinical Study Results

Phase: N/A Priority: Normal
NCT ID: NCT05640180 Org: User:
Start: 11/23/22 End: 12/20/23 Due: 12/20/24

Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT03237416 Org: User:
Start: 08/02/17 End: 12/18/17 Due: 12/18/18

Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)

Phase: N/A Priority: Normal
NCT ID: NCT01947985 Org: User:
Start: 02/01/12 End: 09/30/20 Due: 09/30/21

Efficacy and Safety Study to Evaluate Gadavist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Brain or Spine Diseases in Chinese Patients

Phase: N/A Priority: Normal
NCT ID: NCT00395460 Org: User:
Start: 09/30/06 End: 04/30/07 Due: 04/30/08

Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib

Phase: N/A Priority: Normal
NCT ID: NCT03386825 Org: User:
Start: 01/31/18 End: 05/01/18 Due: 05/01/19

Open Label Study of BAY1082439 in Patients With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01728311 Org: User:
Start: 11/21/12 End: 02/06/17 Due: 02/06/18

Efficacy and Safety Study for the Treatment of Dysfunctional Uterine Bleeding

Phase: N/A Priority: Normal
NCT ID: NCT00293059 Org: User:
Start: 12/31/05 End: 05/31/08 Due: 05/31/09

A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT06412926 Org: User:
Start: 05/07/24 End: 08/27/24 Due: 08/27/25

Advanced Renal Cell Carcinoma, With Failure or Unsuitable on Prior Interferon-alpha or Interleukin-2 Based Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01195649 Org: User:
Start: 12/13/10 End: 08/31/12 Due: 08/31/13

Efficacy and Safety of Polyethylene Glycol 3350 (PEG 3350) for Relief of Constipation (MK-8114-005)

Phase: N/A Priority: Normal
NCT ID: NCT02292459 Org: User:
Start: 12/31/15 End: 12/31/15 Due: 12/31/16

Comparison of Two Omeprazole-Containing Products for Relief of Frequent Heartburn (MK-0764A-036)

Phase: N/A Priority: Normal
NCT ID: NCT01587885 Org: User:
Start: 01/31/12 End: 05/31/12 Due: 05/31/13

A Study to Assess Disintegration of the New Aspirin Disintegrating Tablets

Phase: N/A Priority: Normal
NCT ID: NCT03225352 Org: User:
Start: 08/07/17 End: 10/16/17 Due: 10/16/18

Pharmacodynamic Characterization of Dienogest

Phase: N/A Priority: Normal
NCT ID: NCT00754871 Org: User:
Start: 09/30/08 End: 09/30/09 Due: 09/30/10

Valette (Combined Oral Contraceptive SH T04769G and SH D00659AF) Low Ovulation Inhibition

Phase: N/A Priority: Normal
NCT ID: NCT00471991 Org: User:
Start: 04/30/07 End: 12/31/07 Due: 12/31/08

Drug Use Investigation of Xofigo, Castration Resistant Prostate Cancer With Bone Metastases

Phase: N/A Priority: Normal
NCT ID: NCT02803437 Org: User:
Start: 07/21/16 End: 12/18/24 Due: 12/18/25

Coronary Vasomotor Response After Riociguat Exposure

Phase: N/A Priority: Normal
NCT ID: NCT01165931 Org: User:
Start: 05/31/12 End: 01/31/13 Due: 01/31/14

Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02746081 Org: User:
Start: 05/26/16 End: 12/03/24 Due: 12/03/25